Looking ahead, investors will closely monitor May & Baker’s performance as it navigates rising operating costs and seeks to capitalise on growth opportunities in Nigeria’s expanding healthcare and pharmaceutical sectors. The company’s emphasis on governance, shareholder returns, and leadership continuity is expected to support investor confidence in the coming year.
Leave a Comment